SBC Medical Group Holdings Incorporated (SBC)
Official siteINDUSTRIALS • CONSULTING SERVICES • NASDAQ
Market Cap: $633.93M
Last updated: Nov 17, 2026 at 4:26 PM ET
SBC Medical Group Holdings Incorporated (SBC) Statistics
SBC Medical Group Holdings (SBC) has a market cap of $633.93M and an enterprise value of $469.10M. Its return on invested capital of 16.95% compares with a 0.50% median across 7 similar companies. It holds $164.83M more cash than debt, 26.00% of its market cap.
Total Valuation
Enterprise value is 26.00% below the market cap, as cash exceeds debt.
| Market Cap | $633.93M |
|---|---|
| Enterprise Value | $469.10M |
| Latest price (Nov 17, 2026) | $6.12 |
Key Dates
The next earnings report is expected on Mar 25, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 25, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.3x and 2.2x.
| P/E Ratio | 12.2x |
|---|---|
| Forward P/E | 13.5x |
| P/S Ratio | 3.3x |
| Forward P/S | 3.0x |
| P/B Ratio | 2.2x |
| P/TBV Ratio | 2.8x |
| P/FCF Ratio | 6.3x |
| P/OCF Ratio | 6.2x |
| PEG Ratio | 2.5 |
Enterprise Valuation
Counting debt and cash, the company is valued at 5.3x EBITDA and 4.6x free cash flow.
| EV / Earnings | 8.8x |
|---|---|
| EV / Sales | 2.5x |
| EV / EBITDA | 5.3x |
| EV / FCF | 4.6x |
Price Statistics
The stock is up 84.89% over 52 weeks and trades 17.69% above its 50-day average.
| Beta (1Y) | 0.91 |
|---|---|
| 52-Week Change | +84.89% |
| 1-Month Change | +14.18% |
| 3-Month Change | +58.14% |
| 6-Month Change | +111.76% |
| Total Return (1Y) | +84.89% |
| Return vs SPY (1Y) | +81.50% |
| Max Drawdown (1Y) | -41.67% |
| Max Drawdown (3Y) | -70.14% |
| Sharpe Ratio (1Y) | 1.01 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $5.20 |
| 200-Day Average | $3.98 |
| 52-Week Range | $2.78 to $7.39 |
| RSI (14 Days) | 57.9 |
| Average Volume (20 Days) | 343.77K |
Financial Position
Current assets cover 3.67x current liabilities, and total debt is 0.12x shareholder equity.
| Current Ratio | 3.67x |
|---|---|
| Quick Ratio | 3.63x |
| Debt / Equity | 0.12x |
| Debt / EBITDA | 0.39x |
| Debt / FCF | 0.34x |
| Interest Coverage | 194.48x |
Returns and Efficiency
Return on invested capital is 16.95% and return on equity is 18.54% over the last 12 months.
| Return on Equity (ROE) | 18.54% |
|---|---|
| Return on Assets (ROA) | 12.52% |
| Return on Invested Capital (ROIC) | 16.95% |
| Asset Turnover | 0.51x |
| Inventory Turnover | 17.87x |
| Receivables Turnover | 2.57x |
| Cash Conversion Cycle | -9 days |
Taxes
Income tax took 34.81% of pretax income over the last 12 months.
| Income Tax (TTM) | $29.02M |
|---|---|
| Effective Tax Rate | 34.81% |
Scores
SBC has an Altman Z-Score of 5.68, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.68 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $190.40M over the last 12 months is up 6.69% from the 12 months before.
| Revenue | $190.40M |
|---|---|
| Revenue Growth (YoY) | +6.69% |
| Gross Profit | $137.43M |
| Operating Income | $75.95M |
| Pretax Income | $83.36M |
| Net Income | $53.19M |
| EBITDA | $86.97M |
| Reported EPS (TTM) | $0.50 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 67.52% of the $424.82M in total assets.
| Cash and Equivalents | $198.43M |
|---|---|
| Total Debt | $33.60M |
| Net Cash | $164.83M |
| Net Cash Per Share | $1.61 |
| Working Capital | $199.19M |
| Shareholder Equity | $286.85M |
| Book Value Per Share | $2.80 |
| Tangible Book Value | $226.55M |
| Tangible Book Per Share | $2.21 |
| Total Assets | $424.82M |
| Total Liabilities | $121.35M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $2.01M of capital spending, operating cash flow left $100.20M of free cash flow.
| Operating Cash Flow | $102.21M |
|---|---|
| Capital Expenditures | $2.01M |
| Free Cash Flow | $100.20M |
| FCF Per Share | $0.97 |
| Depreciation and Amortization | $3.65M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 39.89%.
| Gross Margin | 72.18% |
|---|---|
| Operating Margin | 39.89% |
| Pretax Margin | 43.78% |
| Net Margin | 27.94% |
| EBITDA Margin | 45.68% |
| FCF Margin | 52.63% |
Growth
Revenue fell 0.11% a year over 3 years, and EPS grew 132.08% a year.
| Revenue Growth (3Y CAGR) | -0.11% |
|---|---|
| EPS Growth (3Y CAGR) | +132.08% |
| Operating Income Growth (3Y CAGR) | +49.70% |
| Book Value Per Share Growth (2Y CAGR) | +26.64% |
| Tangible Book Per Share Growth (2Y CAGR) | +19.60% |
Dividends and Yields
SBC does not pay a dividend. Its free cash flow yield is 15.96%.
| Earnings Yield | 8.20% |
|---|---|
| FCF Yield | 15.96% |
| Shareholder Yield | 0.00% |
Peer Position
Against 6 similar companies, SBC has the 5th highest P/E.
P/E RatioPeer median 17.2x
P/S RatioPeer median 0.8x
ROICPeer median 0.50%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -5.16%
| P/E Ratio | 12.2x vs 17.2x median |
|---|---|
| P/S Ratio | 3.3x vs 0.8x median |
| ROIC | 16.95% vs 0.50% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.69% vs -5.16% median |
Analyst Forecast
Consensus estimates put revenue growth at 12.20% and EPS growth at 4.98% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +12.20% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +4.98% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SBC
What is SBC's market cap?
SBC Medical Group Holdings has a market cap of $633.93M. Its enterprise value, which adds debt and subtracts cash, is $469.10M.
What is SBC's P/E ratio?
SBC Medical Group Holdings has a trailing P/E ratio of 12.2x and a forward P/E of 13.5x.
How many shares of SBC are outstanding?
SBC Medical Group Holdings has 102.58M shares outstanding. The count is down 0.06% from a year earlier.
Does SBC pay a dividend?
No. SBC Medical Group Holdings does not pay a dividend.
How much debt does SBC have?
SBC Medical Group Holdings has $33.60M of total debt and $198.43M of cash and equivalents, a net cash position of $164.83M.
SBC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors